Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ETX.L Stock Summary
Top 10 Correlated ETFs
ETX.L
In the News
ETX.L Financial details
Company Rating
Sell
Market Cap
71.44M
Income
-19.15M
Revenue
635K
Book val./share
0.05
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
34
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
-15.35
Forward P/E
-
PEG
-1.35
P/S
369.54
P/B
2.49
P/C
275
P/FCF
-20.25
Quick Ratio
19.47
Current Ratio
22.2
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-6.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.66%
Revenue last 5Y
60.93%
Revenue Q/Q
-11.11%
EPS Q/Q
20%
-
-
-
-
SMA20
-19.37%
SMA50
-14.68%
SMA100
13.49%
Inst Own
-
Inst Trans
-
ROA
-15%
ROE
70%
ROC
-0.21%
Gross Margin
100%
Oper. Margin
-3158%
Profit Margin
-2479%
Payout
-
Shs Outstand
584.34M
Shs Float
242.45M
-
-
-
-
Target Price
-
52W Range
8.0-24.0
52W High
-54.17%
52W Low
+37.5%
RSI
35.65
Rel Volume
0.51
Avg Volume
329.53K
Volume
169.64K
Perf Week
-12.21%
Perf Month
-29.49%
Perf Quarter
-8.18%
Perf Half Y
-13.73%
-
-
-
-
Beta
0.478
-
-
Volatility
0.52%, 1.6%
Prev Close
-1.35%
Price
11
Change
-8.33%
ETX.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-01-31
Metric | History | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | |
Operating cash flow per share | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | |
Free cash flow per share | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | |
Cash per share | 0.02 | 0.02 | 0.05 | 0.05 | 0.09 | |
Book value per share | 0.03 | 0.02 | 0.04 | 0.06 | 0.06 | |
Tangible book value per share | 0.02 | 0.02 | 0.04 | 0.06 | 0.06 | |
Share holders equity per share | 0.03 | 0.02 | 0.04 | 0.06 | 0.06 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 14.1M | 10.08M | 71M | 163.59M | 86.51M | |
Enterprise value | 8.2M | 6.31M | 58M | 152.93M | 55.12M | |
P/E ratio | -3.53 | -4.3 | -19.27 | -20.28 | -10.46 | |
Price to sales ratio | 320.47 | 22.11 | 223.99 | 342.97 | 182.13 | |
POCF ratio | -3.81 | -5.01 | -21.25 | -21.11 | -11.47 | |
PFCF ratio | -3.8 | -4.97 | -20.81 | -18.78 | -11.16 | |
P/B Ratio | 2.07 | 2.24 | 5.11 | 5.9 | 2.62 | |
PTB ratio | 2.07 | 2.24 | 5.11 | 5.9 | 2.62 | |
EV to sales | 186.28 | 13.84 | 182.97 | 320.62 | 116.04 | |
Enterprise value over EBITDA | -1.62 | -2.26 | -13.26 | -16.36 | -5.64 | |
EV to operating cash flow | -2.21 | -3.14 | -17.36 | -19.74 | -7.31 | |
EV to free cash flow | -2.21 | -3.11 | -17 | -17.56 | -7.11 | |
Earnings yield | -0.28 | -0.23 | -0.05 | -0.05 | -0.1 | |
Free cash flow yield | -0.26 | -0.2 | -0.05 | -0.05 | -0.09 | |
Debt to equity | -0.03 | 0.02 | 0 | 0.02 | 0.02 | |
Debt to assets | -0.03 | 0.01 | 0 | 0.02 | 0.02 | |
Net debt to EBITDA | 1.17 | 1.35 | 2.97 | 1.14 | 3.21 | |
Current ratio | 10.39 | 17.56 | 33.14 | 19.15 | 21.3 | |
Interest coverage | 0 | 0 | 0 | -954.2 | -445.17 | |
Income quality | 0.93 | 0.86 | 0.91 | 0.96 | 0.91 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 33.75 | 2.72 | 6.6 | 8.25 | 7.33 | |
Research and developement to revenue | 83.48 | 4.61 | 8.53 | 12.81 | 15.21 | |
Intangibles to total assets | 0.02 | 0.02 | 0.01 | 0 | 0.01 | |
Capex to operating cash flow | 0 | 0.01 | 0.02 | 0.12 | 0.03 | |
Capex to revenue | -0.18 | -0.04 | -0.22 | -2.02 | -0.44 | |
Capex to depreciation | -0.15 | -0.17 | -0.87 | -4.99 | -0.45 | |
Stock based compensation to revenue | 1.18 | 0.08 | 1.33 | 1.03 | 0.33 | |
Graham number | 0.09 | 0.06 | 0.09 | 0.15 | 0.15 | |
ROIC | -0.94 | -0.51 | -0.26 | -0.28 | -0.26 | |
Return on tangible assets | -0.54 | -0.5 | -0.26 | -0.27 | -0.24 | |
Graham Net | 0.02 | 0.02 | 0.05 | 0.05 | 0.09 | |
Working capital | 6.64M | 4.32M | 13.72M | 27.11M | 32.41M | |
Tangible asset value | 6.68M | 4.39M | 13.8M | 27.62M | 32.81M | |
Net current asset value | 6.64M | 4.3M | 13.72M | 26.82M | 32.41M | |
Invested capital | -0.03 | 0.02 | 0 | 0.02 | 0.02 | |
Average receivables | 1.29M | 854.5K | 709.5K | 1.27M | 1.73M | |
Average payables | 386K | 95K | 52.5K | 124.5K | 314K | |
Average inventory | -1.29M | -558K | 0 | 0 | 0 | |
Days sales outstanding | 9.26K | 474.66 | 951.07 | 1.31K | 1.35K | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.04 | 0.77 | 0.38 | 0.28 | 0.27 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.59 | -0.52 | -0.27 | -0.29 | -0.25 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-07-31 for Q2
Metric | History | 2021-07-31 | 2022-01-31 | 2022-07-31 | 2023-01-31 | 2023-07-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Operating cash flow per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Free cash flow per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Cash per share | 0.06 | 0.05 | 0.04 | 0.06 | 0.04 | |
Book value per share | 0.06 | 0.05 | 0.05 | 0.06 | 0.05 | |
Tangible book value per share | 0.06 | 0.05 | 0.05 | 0.06 | 0.05 | |
Share holders equity per share | 0.06 | 0.05 | 0.05 | 0.06 | 0.05 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 126.07M | 172.38M | 113.47M | 89.91M | 101.51M | |
Enterprise value | 94.46M | 161.47M | 92.15M | 58.51M | 76.75M | |
P/E ratio | -11.3 | -8.16 | -7.44 | -5.04 | -4.54 | |
Price to sales ratio | 264.29 | 0 | 384.65 | 499.48 | 634.41 | |
POCF ratio | -41.56 | -36.57 | -24.09 | -31.72 | -15.5 | |
PFCF ratio | -40.96 | -30.61 | -23.43 | -30.9 | -15.25 | |
P/B Ratio | 3.82 | 6.16 | 4.66 | 2.72 | 3.69 | |
PTB ratio | 3.82 | 6.16 | 4.66 | 2.72 | 3.69 | |
EV to sales | 198.03 | 0 | 312.39 | 325.06 | 479.69 | |
Enterprise value over EBITDA | -27.29 | -27.41 | -21.37 | -10.72 | -11.46 | |
EV to operating cash flow | -31.14 | -34.25 | -19.57 | -20.65 | -11.72 | |
EV to free cash flow | -30.69 | -28.67 | -19.02 | -20.11 | -11.53 | |
Earnings yield | -0.02 | -0.03 | -0.03 | -0.05 | -0.06 | |
Free cash flow yield | -0.02 | -0.03 | -0.04 | -0.03 | -0.07 | |
Debt to equity | 0 | 0.02 | 0.02 | 0.01 | 0 | |
Debt to assets | 0 | 0.02 | 0.02 | 0.01 | 0 | |
Net debt to EBITDA | 9.13 | 1.85 | 4.94 | 5.75 | 3.7 | |
Current ratio | 39.59 | 19.31 | 22.64 | 21.3 | 22.2 | |
Interest coverage | 0 | -606.5 | -379.58 | -516.73 | -1.74K | |
Income quality | 1.09 | 0.89 | 1.24 | 0.64 | 1.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 3.08 | 0 | 5.85 | 9.76 | 11.29 | |
Research and developement to revenue | 5.27 | 0 | 10.59 | 22.78 | 33.28 | |
Intangibles to total assets | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0.01 | 0.19 | 0.03 | 0.03 | 0.02 | |
Capex to revenue | -0.09 | 0 | -0.45 | -0.42 | -0.68 | |
Capex to depreciation | -1.02 | -5.28 | -0.55 | -0.34 | -0.4 | |
Stock based compensation to revenue | 0.53 | 0 | 0.66 | -0.23 | 0.37 | |
Graham number | 0.09 | 0.11 | 0.09 | 0.1 | 0.1 | |
ROIC | -0.09 | -0.18 | -0.15 | -0.14 | -0.21 | |
Return on tangible assets | -0.08 | -0.18 | -0.15 | -0.13 | -0.2 | |
Graham Net | 0.06 | 0.05 | 0.04 | 0.06 | 0.04 | |
Working capital | 32.84M | 27.36M | 23.66M | 32.41M | 27.06M | |
Tangible asset value | 32.92M | 27.87M | 24.18M | 32.81M | 27.23M | |
Net current asset value | 32.84M | 27.07M | 23.57M | 32.41M | 27.06M | |
Invested capital | 0 | 0.02 | 0.02 | 0.01 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 315.28 | 0 | 723.66 | 879.5 | 1.6K | |
Days payables outstanding | 0 | 570.52 | 0 | 0 | 393.87 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.29 | 0 | 0.12 | 0.1 | 0.06 | |
Payables turnover | 0 | 0.16 | 0 | 0 | 0.23 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.08 | -0.19 | -0.16 | -0.14 | -0.2 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ETX.L Frequently Asked Questions
What is e-therapeutics plc stock symbol ?
e-therapeutics plc is a GB stock and trading under the symbol ETX.L
What is e-therapeutics plc stock quote today ?
e-therapeutics plc stock price is $11 today.
Is e-therapeutics plc stock public?
Yes, e-therapeutics plc is a publicly traded company.